Clinical Trial Update: A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression [Phase 4]

View source ↗

Summary

A Phase 4 safety and efficacy study of escitalopram for acute treatment of severe major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED